Tuesday, Jan 28, 2025 · SEC filings

What the smart money revealed on Jan 28

Real insider buys21insiders · $6.86M
Real insider sales41insiders · $32.3M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

567 insider filings came in. We hid 28 planned (10b5-1) sellers and 467 people whose filings were routine, like grants and tax withholding.

trending_up

Variant Alternative Lending Fund (XALFX) President Robert Elsasser bought $6.28M

250,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 24–28
$6.28M
trending_up

Texas Capital Bancshares (TCBI) Director Robert Stallings bought $199K

Open-market buys of more than one share class. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 7 of 9 beat Traded Jan 24–27
$199K
trending_up

Mid Penn Bancorp (MPB) President and CEO Rory Ritrievi bought $91.6K

3,050 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 4 beat Traded Jan 27
$91.6K
trending_up

Bankwell Financial Group (BWFG) Director Kevin Leitao bought $60.8K

2,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 27
$60.8K
trending_down

Core Scientific (CORZ) CEO Adam Sullivan sold $6M

Not marked as a planned 10b5-1 sale. Sold 9% of the shares they held directly. Still holds 3.76M shares.

Real sale Form 4 Traded Jan 24
$6M
trending_down

Ryan Specialty (RYAN) Director Nicholas Cortezi sold $4.56M

Not marked as a planned 10b5-1 sale. Sold 64% of the shares they held directly. Still holds 39,958 shares.

Real sale Form 4 Sold 64% of stake Traded Jan 27–28
$4.56M
trending_down

Blackberry (BB) SVP and Chief Accounting Officer Jay Chai sold $102K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jan 24
$102K
Show 17 more real buys
Show 38 more real sales
TDY Teledyne Technologies · EVP Melanie Cibik · Traded Jan 27–28
$3.78M
BKR Baker Hughes · EVP Maria Borras · Traded Jan 27–28
$3.28M
GS Goldman Sachs Group · Global Treasurer Carey Halio · Traded Jan 24
$2.32M
UNP Union Pacific · President Elizabeth Whited · Traded Jan 24
$1.88M
CBSH Commerce Bancshares · Executive Vice President Kevin Barth · Traded Jan 24–27
$1.72M
UNP Union Pacific · EVP Chief Legal Officer and Corp Craig Richardson · Traded Jan 27
$1.64M
MMM 3M · EVP Kevin Rhodes · Traded Jan 27
$1.01M
AAL American Airlines Group · SVP Corporate Controller Angela Owens · Traded Jan 27
$890K
WEAV Weave Communications · CEO Brett White · Traded Jan 27
$869K
MMM 3M · Executive Vice President John Banovetz · Traded Jan 27
$726K
MMM 3M · EVP and Chief HR Officer Zoe Dickson · Traded Jan 27
$543K
CORZ Core Scientific · Officer Todd Duchene · Traded Jan 24
$410K
WEAV Weave Communications · Chief Product and Technology Ofcr Branden Neish · Traded Jan 27
$329K
MBWM Mercantile Bank · Director Robert Kaminski · Traded Jan 24–27
$298K
PLMR Palomar · CEO and Chairman Mac Armstrong · Traded Jan 26
$284K
MMM 3M · Group President Beatriz Chavez Rodriguez · Traded Jan 27
$247K
ILLR Triller Group · Director Robert Diamond Jr. · Traded Jan 24–28
$210K
CBSH Commerce Bancshares · Executive Vice President John Handy · Traded Jan 27
$182K
TRAK ReposiTrak · CEO Randall Fields · Traded Jan 27–28
$157K
ADBE Adobe · SVP and CAO Jillian Forusz · Traded Jan 28
$146K
PFC Premier Financial · Director Nikki Lanier · Traded Jan 24
$83.5K
EWBC East West Bancorp · Director Jack Liu · Traded Jan 28
$75.8K
CBU Community Financial System · SVP and Chief Banking Officer Jeffrey Levy · Traded Jan 24
$75K
PLMR Palomar · Chief Legal Officer Angela Grant · Traded Jan 26
$72.9K
KURA Kura Oncology · Chief Legal Officer Teresa Bair · Traded Jan 28
$57.3K
NE Noble · SVP Caroline Alting · Traded Jan 26
$54.1K
USQIX USQ Core Real Estate Fund · Director Gregory Fairchild · Traded Jan 24
$50K
PLMR Palomar · CFO T. Christopher Uchida · Traded Jan 26
$40.1K
KURA Kura Oncology · Chief Medical Officer Mollie Leoni · Traded Jan 28
$39.1K
KURA Kura Oncology · SVP Thomas Doyle · Traded Jan 28
$38.9K
PLMR Palomar · President Jon Christianson · Traded Jan 26
$37.7K
PLMR Palomar · Chief Risk Officer Jonathan Knutzen · Traded Jan 26
$28.3K
KURA Kura Oncology · Chief Scientific Officer Francis Burrows · Traded Jan 28
$17K
KURA Kura Oncology · COO Kathleen Ford · Traded Jan 28
$14.3K
KURA Kura Oncology · Chief Commercial Officer Brian Powl · Traded Jan 28
$12.5K
CBUS Cibus · Director Gerhard Prante · Traded Jan 27
$2.73K
DRCT Direct Digital · Director Mistelle Locke · Traded Jan 16
$2.3K
FMC FMC · EVP - Integrated Supply Chain Thaisa Hugenneyer · Traded Jan 27
$223

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 22–28

Open-market buys by officers and directors, filed in the 7 days up to Jan 28.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist